NTBC and alkaptonuria.
Y
Y
Anikster
W L
WL
Nyhan
W A
WA
Gahl
D015111:4-Hydroxyphenylpyruvate Dioxygenase / Q000037:antagonists & inhibitors; D000474:Alkaptonuria / Q000188:drug therapy*; D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy; D003512:Cyclohexanones / Q000009:adverse effects / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009579:Nitrobenzoates / Q000009:adverse effects / Q000627:therapeutic use*; D014443:Tyrosine / Q000097:blood
D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; D014443:Tyrosine; D015111:4-Hydroxyphenylpyruvate Dioxygenase; C077073:nitisinone